Skip to main content
Premium Trial:

Request an Annual Quote

Primera Raises $21M To Support Development of PCR-Based Dx System

NEW YORK (GenomeWeb News) - Primera Biosystems said this week that it has raised $21 million in series B financing that it will use to develop diagnostic instrument and reagent kits for clinical research.
 
The funding round was led by Abingworth and included investments from Interwest Partners, Malaysian Technology Development Corporation, MPM Capital, Burrill & Company, and the Invus Group.
 
Primera is developing the Scalable Target Amplification Routine platform, or STAR, a bench-top quantitative real-time PCR system.
 
The company is also developing an assay to measure multiple viral agents to cause infections in immune comprised patients and a multiplex fungal test, both using the STAR system.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more